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Abstract
Aortic aneurysms are of different types as different ones are the types of  
treatment available to us. Following the advent of endovascular surgery, periopera-
tive mortality has been significantly reduced, but open surgery remains the first 
choice under some occurrences. The purpose of this chapter is to try to clarify the 
dichotomy between open and endovascular aortic aneurysms in the several types 
of aortic aneurysms, highlighting the indications and complications to guide to the 
best therapeutic choice.
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1. Introduction
The aortic aneurysm is defined as a pathological condition characterized by 
permanent dilation of the aortic wall that most often occurs in the infra-renal 
region and the aortic arch. It generally presents asymptomatically, but progressive 
dilation can lead to the aorta rupture until the patient’s death of the patient [1].
Based on autopsy studies, it is estimated that about 1–2% of the population has 
an aortic aneurysm, increasing to 10% in the older population [2]. In the United 
States, an aortic aneurysm rupture is in thirteenth place due to cause of death [2]. 
Abdominal aortic aneurysms (AAA) are the most common type, and most of them 
are atherosclerotic. The ascending tract aneurysms (ATAA) instead of the present 
as the most common etiology medial degeneration, a process normal in aging, but 
which accelerates pathologically if the person has other disorders, such as hyper-
tension, bicuspid aortic valve, or genetic alterations [2].
2. Etiology
The etiology of aneurysm formation is not yet exact connoted. Aneurysmal 
disease main problem is the wear of the aortic wall, which progressively increases its 
dilation and the risk of rupture [3].
Biochemical studies have shown that there is a decrease in elastin in this 
pathology as opposed to a more significant increase in the share of collagen, 
increasing the ratio of collagen to elastin in the aneurysmal wall [4, 5].
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Animal tests have highlighted that the aortic wall weakening is also due to the 
intervention of matrix metalloproteases, which act on the degradation of elastin 
and the destruction of smooth muscle cells [4].
Infections are an uncommon cause of aneurysmal pathology, with cases ranging 
from 0.65% to 1.3% of cases. Most are attributable to staphylococci, but strepto-
cocci, salmonella, and syphilis can also occur [6, 7].
Fungal infections are sporadic, but there are some documented cases [6].
Among the genetic disorders predisposing to this type of disease, we have 
Ehlers-Danlos, a hereditary connective tissue disorder, specifically type IV, which 
induces an autosomal dominant collagen type reduction III [8].
Another autosomal dominant genetic pathology of connective tissue is Marfan 
syndrome. People with this pathology present a mutation of the fibrillin gene, 
predisposing them to aortic aneurysms, dissection, mitral insufficiency, deformities 
of the chest wall, joint laxity, and increased arm and leg length [9].
Another one is the Loeys-Dietz syndrome, an autosomal dominant pathology 
characterized by arterial tortuosity and aneurysms, hypertelorism, and bifid uvula 
or cleft palate. To be suspected in cases of aortic dissection or aneurysmal rupture in 
young patients [10].
3. Natural course
Familial thoracic aortic aneurysms (TAA) grow faster, up to 2.1 mm/year. There 
are also various growth rates of syndromic TAA. In patients with Marfan syndrome, 
TAA growth rates are on average 0.5–1 mm/year, while TAA in patients with Loeys-
Dietz syndrome (LDS) can grow even faster than 10 mm/year, causing death at an 
average age of 26 years [11–14].
Descending TAA (DTAA) grew more (at 3 mm/year) than ascending TAA 
(1 mm/year). Marfan syndrome patients with aortic valve disease and aortic dissec-
tion who underwent reparative surgery had TAA growth of 0.58 + 0.5 mm/year for 
the descending aorta. Factors influencing the growth of aortic diameters over time 
are hypertension, emergency procedures, and aortic dissection [15].
The dissection risk or rupture hazard increases rapidly when the aorta diameter 
is >60 mm for ATAA and > 70 mm for DTAA. Although dissection can occur in 
patients with a small aorta, the individual risk is very small [16].
AAA has a very long estimated asymptomatic growth period of approxi-
mately 1–6 mm/year. Several risk factors may contribute to its growth and 
progression such as genetic and environmental factors, among which smoking 
stands out as a determinant for rapid growth. The growth rate of the aneurysm 
increases in proportion to its size. Diameter has an exponential effect on the risk 
of rupture and women have a greater risk of rupture at diameters 10 mm smaller 
than men [17].
4. Clinic
An accurate anamnesis and objective examination must be performed. Most 
aneurysms are incidentalomas, occasional findings, highlighting chronicity, and 
growth rate. It investigates whether you are faced with a smoker if you have expe-
rienced weight loss, abdominal pain, fever, or intestinal bleeding over time. It is 
necessary to study the person from the renal point of view, as a situation of moder-
ate or severe renal failure increases the morbidity and mortality of the subject. 
The patient’s abdomen’s objective examination is performed to see if a pulsatile 
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abdominal mass is appreciated. Also, a cardiological objective examination is 
performed for arrhythmias or valve defects [18].
For this pathology’s diagnostic and therapeutic treatment, a division between 
thoracic aorta aneurysms and abdominal aneurysms is performed. This dichotomy 
is artificial, as there are thoracoabdominal aneurysms and the possibility of mul-
tiple lesions in both areas. The presence of an aortic aneurysm can be associated 
with aneurysms in other regions. During diagnostic tests, aneurysms of the iliac 
vessels can also be observed, but those of the popliteal vessels can escape instead. 
Some studies report that the prevalence of popliteal aneurysms on aortic aneurysm 
pathology maybe 14% [19].
People with TAA are often asymptomatic, and the diagnosis is often sup-
ported by images taken for other reasons or screening. In Marfan syndrome, 
aortic widening is generally maximum in Valsalva sinuses, responsible for 
anuloaortic ectasia [20].
Asymptomatic patient is also present in the abdominal aortic aneurysm. 
The sensitivity of the objective examination is low. People may present with 
atypical abdominal pain or lumbar pain, but it is not enough to alarm us for this 
pathology.
Acute abdominal pain with shock is often present in cases of aneurysmal rup-
ture. Ultrasonography is an excellent tool for screening and surveillance, with no 
proven risks and low costs. It becomes useful during echocardiography to evaluate 
aortic necessary for the future investigated by other diagnostic tools [21].
The CT scan with intravenous contrast medium (IV contrast) is the diagnostic 
method for intervention planning. It also allows you to create a virtual angiogram 
with 3D reconstructions to study the organ ratios. It can also evaluate the coexis-
tence of aneurysms or occlusive pathology at the level of the iliac or femoral artery 
sectors [22].
MRI with contrast medium, and without it, is the main examination in patients 
allergic to IV contrast or case of pregnancy of the patient and allows an accurate 
study of soft tissue, although it does not show calcifications within the aortic wall.
5. Intervention criteria
For the ATAA, the intervention is based on the diameter of the vessel and the 
patient’s medical history, evaluating the risks and benefits of surgical intervention 
in the election. The surgery should be performed in patients with Marfan syndrome 
and a maximum diameter greater than or equal to 50 mm [23].
Diameters of 45 mm may be considered eligible for surgery in cases with mul-
tiple risk factors such as the family history of aortic dissection, increased diam-
eter > 3 mm/year, severe aortic regurgitation, or desire for pregnancy [24].
Surgery should be considered in patients with a bicuspid aortic valve with a 
diameter greater than or equal to 55 mm. The limit may drop to 50 mm in patients 
with multiple risk factors, such as hypertension, aortic coarctation, familiarity, or 
a 3 mm/year increase in aneurysmal diameter. Without considering etiology, the 
surgery should be performed in patients with an aortic diameter greater than or 
equal to 55 mm.
The treatment is also indicated in patients with saccular aneurysms, pseudoa-
neurysms, symptomatic aneurysms and is also recommended for patients who 
need valve surgery, considering eligible those who have formations with diameters 
greater or equal to 45 mm [25, 26].
In aortic arch aneurysms, the surgery is performed for diameters greater than 
or equal to 55 mm or where the compressive symptomatology is very evident. The 
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decision must be accompanied by postoperative risk assessment, as replacement 
surgery is associated with increased mortality and stroke possibilities [27].
In descending aortic aneurysms, the use of stent-graft positioned by endovas-
cular technique prevails. Endovascular surgery should be considered for aneurysms 
with a diameter greater than or equal to 55 mm. In cases where an open procedure 
must be performed, the indications are for diameters greater than or equal to 
60 mm. Lower limits should be considered in patients with Marfan syndrome [28].
We recommend periodic ultrasound monitoring in AAA until it reaches diam-
eters more significant than 55 mm, if it becomes symptomatic or if it increases its 
growth rate to values >10 mm/year [29].
6. Treatment
Until the advent of endovascular surgery, open surgery was the only possibil-
ity of treatment in cases of descending thoracic aortic aneurysm. Postoperative 
mortality from open surgery was 10% [30].
Over 40% of patients experience perioperative cardiopulmonary complica-
tions. According to some authors, perioperative mortality is about 3%, and the 
risk of complications like paraplegia increasing values between 0 and 4%. That is 
true in the open and the endovascular approach, and it may be due to spinal cord 
ischemia [31].
Since the use of stent-graft for endovascular surgery has been approved, this 
method has increasingly replaced open techniques. Post-operative mortality has 
decreased between 1.5% and 7%, with paraplegia risk between 1% and 3% [32, 33].
Open surgery should be considered in young patients with a low risk of periop-
erative complications.
Successful endovascular surgery depends on proximal implantation, distal to the 
left subclavian artery, and distal to the thoracic aorta or extending to the abdominal 
aorta above the celiac tripod. It is generally performed with one or more stent-graft 
tubes, and the choice of devices depends on the surgeon’s anatomical characteristics 
and experience.
Open surgery remains an essential treatment for patients with altered anatomy, 
in young patients with few comorbidities, and in genetic collagen disorders. The 
operation involves replacing the aortic aneurysmal portion with a tube graft, 
performed by left thoracotomy [31].
During the clamping, perfusion is maintained by right or left cardiac by-pass, 
allowing for less postoperative morbidity and mortality [34].
With the left by-pass, the oxygenated blood is taken directly from the left 
pulmonary vein or left atrium and infused by the femoral artery’s cannulation. 
The right by-pass allows greater hemodynamic control but requires higher levels 
of heparinization and therefore bleeding. The distal clamp is placed just below the 
proximal anastomosis, maintaining perfusion in almost the entire thoracic aorta as 
the proximal anastomosis is completed.
When distal aortic perfusion is not used, the repair is achieved with a clamp 
and seam technique, in which the aorta is clamped and repaired in sequence, with 
attention to speed to minimize distal ischemia time.
During the open operation, the number and location of the segmental arteries 
involved in the repair are predictive of the risk of spinal cord ischemia. In a wide 
range of open procedures, spinal cord ischemia was rare if the segmental arteries 
involved were < 8 but was 12.5% if >13. Before opening the aneurysm sac, the men-
tal arteries are cut or clamped to avoid back bleeding and subsequent theft from the 
spinal cord [35].
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Abdominal, thoracic aneurysms involve various extensions of the aorta, from 
the left subclavian artery to the aortic bifurcation, all with some degree of involve-
ment of visceral segmentation. Currently, open surgery remains the therapy of 
choice in the United States. Successful surgery involves replacing the diseased aorta 
through a large left thoracoabdominal incision. When the entire visceral segment is 
involved, the renal and mesenteric arteries are reconstructed through a Carrel patch 
(typically a single patch for the right renal artery, the superior mesenteric artery, 
and the celiac trunk with a separate left renal by-pass), or a Coselli graft with a 
branch to each visceral vessel.
A branched graft is preferred for patients with congenital aortic disease, as these 
patients are at high risk of patch aneurysms. The need for exposure, dissection, and 
reconstruction of the visceral segment makes the repair of the thoracoabdominal 
aorta aneurysm technically complex and highly morbid. Postoperative mortality 
in high-volume centers has been reported as low as 8%. However, the National 
Surgical Quality Improvement Program and National In-patient Sample mortality 
was 10% and 22%, compared to 2% [36–38].
Half of the patients suffer from postoperative pulmonary, cardiac, and renal 
complications [36, 37].
Techniques have been developed to maintain distal perfusion and minimize 
renal and visceral ischemia during the reconstruction of the thoracoabdominal 
aorta aneurysm. In most cases, cardiopulmonary by-pass with femoral arterial 
cannulation is used to maintain distal perfusion. During the reconstruction of the 
visceral segment, renal ischemia is mitigated by direct perfusion of the renal arter-
ies with cold crystalline solution or blood from the by-pass circuit. Visceral perfu-
sion is also maintained with blood from the by-pass circuit. Besides, mild systemic 
hypothermia is often used to minimize the impact of ischemia [39].
There are no commercially available devices approved for total endovascular 
TAA repair in the United States. However, a hybrid type II TAA repair with 
thoracic aortic aneurysm repair (TEVAR) has been described, followed by open 
replacement of the remaining visceral segment and abdominal aorta involved. 
That can be performed either as a single-stage repair or as a 2-stage repair. While 
postoperative mortality is similar, there is evidence that a staged approach, either 
when performing a hybrid or open repair, is associated with a lower risk of spinal 
cord ischemia (SCI) [40, 41].
Aortic arch aneurysms are usually treated in conjunction with the treatment of 
an ascending or descending aneurysm. The arch is best exposed through a median 
sternotomy and most often is replaced with a branched graft with an individual 
branch for each vessel of the arch. Arch replacement is associated with significant 
early morbidity and mortality and involves substantial risk of neurological compli-
cations, both from cerebral ischemia and embolization. In most cases, arch repo-
sitioning is performed in hypothermic circulatory arrest. The cerebral blood flow 
can be maintained with selective cerebral perfusion prior to the degree of cerebral 
perfusion.
In the endovascular era, 2 techniques for hybrid aortic arch repair using a 
combination of open and TEVAR surgery have been developed. Eradication of the 
supraoptic arch involves by-passing all 3 branches of the arch from the ascending 
aorta, followed by the TEVAR, including the arch. The proximal holding area is in 
the non-aneurysmal ascending aorta or proximal arch. The alternative approach is 
the endovascular modification of the elephant truck technique, used for patients 
with ascending and descending aneurysms. With this technique, the aortic arch is 
replaced with a branched graft that includes an extension of the distal tube graft. 
This is extended distally into the descending thoracic aorta beyond the distal anas-
tomosis. The pathogenesis of the ascending aorta aneurysm is different from that of 
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descending aneurysms and abdominal aorta in many cases. It frequently occurs in 
patients with Marfan syndrome and other disorders of familial connective tissue or 
bicuspid aortic valves [42].
In addition, isolated ascending aortic aneurysms are rare, as most occur in con-
junction with aortic root aneurysms and arch aneurysms. Therefore, ATAA repair is 
often performed in conjunction with additional procedures [43].
For aneurysms involving root aneurysms, surgery can be achieved by aortic root 
and/or ascending tract replacement and aortic valve replacement or reimplantation 
or composite aortic valve, root, and ascending aorta replacement with coronary 
artery reimplantation (Bentall procedure).
Recently, endovascular techniques have been introduced in the ascending aorta. 
The Zenith Ascend TAA Endovascular Graft (Cook Medical, Bloomington, IN) is 
a device dedicated to the ascending aorta that has been used for type A and ATAA 
dissection. However, its use remains experimental and is not approved by the Food 
and Drug Administration for commercial use in the United States [44].
Before the 1990s, open surgery was the only treatment option for abdominal 
aortic aneurysms and, while continuing to provide more remarkable survival 
than observation, was characterized by high morbidity and postoperative 
mortality [45].
However, the paradigm of intervention on AAA changed forever after the intro-
duction of endovascular repair of AAA (EVAR), first described by Parodi et al. [46].
Since then, the use of endovascular techniques in treating aortic aneurysms 
has expanded considerably, and EVAR is now the primary treatment for AAA. 
Before the endovascular era, surgical mortality after AAA repair was ≈5%. After 
EVAR adoption, overall operating mortality from AAA repair dropped to 2.4% 
in 2008 [47].
The rapid adoption of EVAR has provided a AAA treatment option for many 
patients who are not candidates for open surgery. Instead, they remain patients 
with anatomical constraints that preclude the Use of EVAR. Young and other-
wise, healthy patients may benefit from open surgery due to its longer duration. 
Also, patients with anatomical features that make it more likely to require revi-
sion, such as a highly angled neck, may benefit from an open approach. Finally, 
patients with connective tissue disorders should be treated with an open approach 
if possible, since long-term endovascular complications are inevitable in this 
population secondary to their disease progression. In addition to patients with 
substantial medical comorbidity, EVAR is preferred in patients for whom an open 
intervention would pose additional technical challenges, such as patients with a 
hostile abdomen. For patients who are eligible for both EVAR and Open, a shared 
decision-making process based on an in-depth discussion of each approach’s risks 
and benefits is essential.
EVAR excludes an aneurysm from the bloodstream through the placement of a 
bifurcated stent, most introduced through the femoral arteries. The bag’s exclusion 
depends on adequate proximal and distal sealing between the graft tissue and the 
vessel wall. For AAA under renal, the abdominal endovascular aortic aneurysm 
operation is performed with proximal fixation in the neck under renal and distal 
fixation in the common iliac arteries. The graft choice depends on anatomical 
criteria, the availability of the device, and the experience/preference of the surgeon. 
While each graft has been evaluated through prospective trials, the direct compari-
son between graft types is limited. In addition to neck length, angle, and diameter, 
other features that affect proximal hold are calcification of the neck, reverse taper-
ing, and mural thrombus.
Some devices use suprarenal fixation to improve proximal tightness, where an 
uncovered stent extends over the renal arteries. Observational studies have shown 
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that suprarenal fixation is associated with a slightly higher risk of postoperative 
renal complications [48, 49]. When selecting a device that uses fixation above the 
renal arteries, this difference should be weighed against the potential improvement 
in proximal fixation.
Sub-renal devices are designed to fixate distally in the common iliac artery 
(CIA). However, aneurysmal CIAs presents a technical challenge as they prevent 
proper distal implantation. Surgeons have overcome this obstacle with 2 techniques: 
internal iliac artery embolization (IIA) and branched iliac devices.
Open AAA repair consists of replacing the aneurysmal segment with a synthetic 
graft. In most cases, a tubular graft from the renal neck to the bifurcation is enough. 
However, if the bifurcation or proximal CIA is diseased, a bifurcated graft can be 
used. The successful repair depends on the exposure of the abdominal aorta and 
proximal and distal vascular control.
For surgery, the abdominal aorta is exposed through a transperitoneal or retro-
peritoneal approach.
A transperitoneal approach is performed with the patient in a supine position 
through a midline laparotomy. It provides rapid access to the distal abdominal 
aorta and bifurcation. The aneurysm’s neck is exposed by packing the intestine into 
the right abdomen and dividing the Treitz ligament. A retroperitoneal approach 
is performed with the patient in the right lateral decubitus position through an 
incision on the left side that extends inferiorly parallel to the right abdomen. The 
peritoneal and retroperitoneal contents are moved anteromedially, exposing the 
entire abdominal aorta and the left iliac artery. It provides excellent visceral seg-
ment exposure; however, exposure of the right CIA bifurcation can be occasionally 
difficult. The choice of exposure depends on the patient’s anatomy and the surgeon’s 
preferences. Patients with hostile neck anatomy or short neck may benefit from a 
retroperitoneal approach and improved visceral segment exposure. Conversely, 
patients with right CIA aneurysms requiring a bifurcated graft may benefit from a 
transperitoneal approach.
With the aorta exposed, vascular control is achieved. During AAA repair, an 
aortic, renal cross-clamping position should be used whenever possible. Suprarenal 
clamping is associated with higher rates of acute renal injury (AKI) and higher 
overall complication rates [50].
Hostile neck anatomy may require an adrenal clamp position. In such cases, an 
attempt should be made to minimize renal ischemia time, and the clamp should 
be moved distally once the proximal anastomosis is completed. Distal control is 
achieved with bilateral CIA clamping or balloon occlusion if adequate distal control 
cannot be achieved through a cross-clamp.
Once access is obtained, the bag is opened, the thrombus is removed, and the 
aneurysmal segment is replaced with a synthetic graft [51].
7. Complications
Any manipulation of the aortic arch carries the risk of carotid artery emboliza-
tion and subsequent stroke. This risk is magnified in patients with a very proximal 
implant area, mural thrombus in the arch, or history of previous stroke [52].
Stroke of the posterior circulation can also occur due to coverage of the left sub-
clavian artery or embolization through the subclavian. Before TEVAR performing a 
carotid-subclavian by-pass can reduce this risk and benefit from improving the risk 
of paraplegia [53–55].
Paralysis due to spinal cord ischemia is a very feared risk in TEVAR. Risk factors 
include extensive coverage of the thoracic aorta, preventive AAA repair, and the left 
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subclavian artery coverage. Visceral ischemia can occur with intentional or uninten-
tional coverage of the origin of the celiac artery. An intact pancreatic-duodenal arch 
may reduce this risk [56].
The large device diameter required for the TEVAR requires a relatively large 
sheath of 20 to 26F. It is essential to evaluate patient access through femoral and 
iliac vessels to preoperative CT to minimize access problems. Calcified, small, 
tortuous vessels are the most at risk. When an iliac rupture occurs, balloon occlu-
sion can be used for temporary vascular control until the artery can be repaired. 
Reports suggest that 9.4 to 23.8% of patients require non-standard techniques for 
safe access [57–59].
Fever and leukocytosis may occur in the immediate postoperative period due 
to activation of the endothelium reacting to stent placement, to be considered in 
patients with elevated inflammatory markers and pleural effusions with an other-
wise harmful infectious analysis [60–64].
Post-implantation graft migration occurs with an incidence from 1 to 2.8% 
[65]. Indeed, aortic tortuosity and graft oversizing are associated with migration 
risk [66].
Patients with traumatic aortic rupture may be particularly at risk of graft 
failure, possibly due to morphological differences in the unhealthy aorta [67]. 
Endoleak is relatively rare after TEVAR, with rates reported in the literature 
ranging from 3.9 to 15% [68].
The risk of death is about 4% in patients with uncomplicated aortic aneurysms. 
The most common etiology of death is myocardial infarction. For patients with a 
ruptured aortic aneurysm, mortality can reach 80%. The abdominal wall’s retro-
peritoneal incision is associated with a weakening of the lateral abdominal wall 
muscles, resulting in swelling of up to 15% of patients. Trans peritoneal incision is 
associated with a 12–20% risk of ventral hernia formation [69, 70].
The para-anastomotic aneurysm risk is about 0.8% at 5 years, 6.2% at 10 years, 
and is close to 20–40% at 15 years after open surgery. Several factors influence the 
risk of postoperative renal failure. These include a longer renal ischemia time, the 
division of the left renal vein, the bilateral suprarenal aortic clamp position, and 
the use of additional renal artery procedures. In a juxta-renal aneurysm repair 
study, postoperative transient renal dysfunction occurred in 37% of patients, with 
the majority resolving by the end of hospital stay [71].
Colon ischemia can vary significantly in severity. It can be isolated to the mucosa 
of the colon, or it can be transmural. The incidence of colon ischemia is 1–3% after 
elective repair and up to 10% after the broken AAA emergency repair. A routine 
postoperative colonoscopy has been performed in centers where the incidence is 
even higher: 5–9% after elective repair and 15–60% after rupture. The etiology of 
colon ischemia may include non-obstructive ischemia due to shock or vasopressin 
medication, occlusion of the lower mesenteric artery and/or internal iliac arteries 
and/or atheroembolization. Risk factors associated with colon ischemia develop-
ment have included the type of repair, rupture, duration of surgery, kidney disease, 
lung dysfunction, blood loss, femoral anastomosis, and loss of the hypogastric 
artery [72].
Sexual dysfunction is common in patients with peripheral arterial disease. 
As shown in the DREAM study, preoperative sexual dysfunction in the group of 
patients undergoing open surgery and, in the group, undergoing EVAR was 66% 
and 74%, respectively. The data analyzed after surgery show a greater level of 
sexual dysfunction in the open group and returned to normal after 1.5 months in 
the EVAR group and 3 months in the open group [73].
Postoperative sexual dysfunctions’ incidence in the two treatments was 
estimated later, indicating 7.4% in open surgery and 4.7% in EVAR treatment, 
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equalizing sexual function at 1-year follow-up in the two groups according to the 
ACE analysis [74].
Graft infection complicates about 0.3% of all aortic operations. In endovascular 
and open aortic aneurysm operations, infection rates are low. Staphylococcus spp. is 
responsible for most infections followed by gram-negative bacteria. Infection tends 
to appear on average 3 years after surgery. Treatment includes removal of the graft 
and infected or necrotic tissue by extra-anatomic bypass or in situ repair [69, 75].
Advantages of extra-anatomic bypass include placement of a prosthetic graft 
through a noninfected field, excision in one or two settings, and easily accessible 
axillary and femoral arteries for relatively rapid surgery, but the risk of aortic 
stump rupture with fatal consequences is 33%. Extra-anatomic graft infection can 
be observed in up to 20% of patients and graft occlusion with limb loss in 27% of 
cases [76].
The extra-anatomic by-pass is not a viable option when the infrarenal aorta is 
insufficient to create an aortic stump. In this situation, an in-situ by-pass should be 
considered with the use of an antibiotic-impregnated graft, an aorta taken from a 
corpse, or an autologous venous by-pass. Normally rifampicin is used to impregnate 
the Dacron graft for antistaphylococcal and partially anti gram-negative action. 
Advantages of using Dacron include easy availability of materials and the absence of 
an aortic section. The procedure with neoaortoiliac system uses homologous grafts 
of femoropopliteal vein, which do not need anticoagulation therapy, to replace the 
injured wall and through the in-situ approach it is possible to avoid sectioning the 
aorta. Problems with this procedure include the need for a preintervention to obtain 
the vessel and the possibility that it may not meet the predetermined length [77].
An aortoenteric fistula (AEF) is a connection between the third or fourth por-
tion of the duodenum and the aorta. Most aortoenteric fistulas occur after aortic 
surgery, making primary aortic fistulas an infrequent condition. The incidence 
of AEF has been reported up to 4% of aortic repairs. AEF causes aortic and graft 
infection and can cause bleeding. Symptomatology includes abdominal pain, fever, 
melena or hematemesis, and weight loss. Treatment includes control of excessive 
blood loss, peripheral organ perfusion and treatment of the infection.
The treatment option in open surgery involved the use of a bypass to allow 
resection of the infected tract and repair of the gastrointestinal tract injury. EVAR 
has also been studied in the setting of aortoenteric fistulas. In a revision of EVAR 
for AEF, persistent/recurrent infection or recurrent bleeding may occur in 44% 
of patients following the procedure and with a mortality rate of 29% due to septic 
complications in most cases [78].
Limb ischemia is a complication that can occur in up to 25% of cases of open 
surgery. It tends to occur more for grafts reaching the femoral arteries and in the 
female population [79].
The types of treatment are based on removal of the thrombus by endovascular 
secondary intervention or open. The most frequent complication in EVAR treat-
ment involves endoleaks, which occur in up to 25% of cases in the postoperative 
period. There are different presentations of endoleaks. Type I represents incomplete 
adhesion between the aortic wall and the endovascular device, in turn dividing into 
two subtypes: Ia for the proximal complication and Ib for the distal one. When pres-
ent, it must be treated as it is associated with a high risk of rupture due to increased 
pressure within the pouch [80, 81].
It can be treated with an open approach if resolution by endovascular surgery 
is not possible. The most common type of endoleak is type II, found in 10–20% of 
patients. The primary cause is a reversal of flow in the inferior mesenteric artery 
(IMA) or lumbar artery that carries blood within the aneurysmal sac. It undergoes 
spontaneous reslution in 50–60% of cases within 30 days [82].
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Type II endoleaks were not associated with an increased risk of sac rupture, so 
they should not be treated. However, surgical treatment will be necessary in type II 
endoleaks if they are associated with increased pressure in the aneurysmal sac or if 
they do not spontaneously recede. They can be treated by retrograde trans arterial 
catheterization, direct puncture of the sac, or by laparoscopy.
Patients with type II endoleak had more significant complications (death, 
rupture, reintervention, or conversion to open surgery) and increased aneurysm 
sac enlargement. Type II endoleak was determined as a risk factor for the growth of 
the aneurysm diameter greater than 5 mm, especially if type II endoleak persisted 
for more than 6 months and was recurrent or associated with a type I and/or III 
endoleak [83].
A type III endoleak arises from a poor seal between the components or from a 
separation of the frank components. It is associated with the sacralization of the 
aneurysm and increased risk of rupture.
It must be treated when found. It can be treated either with a stent replace-
ment for low leakage or with aortoiliac devices and a femoral-femoral by-pass for 
component separation.
A type IV endoleak refers to diffuse contrast redness seen occasionally immedi-
ately after implantation. It reflects the porosity of the graft material and is usually 
self-limiting and does not require treatment. Endoleak, also called type V endoleak, 
occurs when an aneurysm sac continues to be pressurized, and there is no exact 
source of endoleak. Management options include endograft realignment, open 
conversion with explantation and lumbar/IMA supervision if the culprit is found, 
or explantation with open surgery.
Aneurysm rupture after EVAR continues to be a significant driver of frequent 
postoperative follow-up in EVAR patients. The ACE study found a 2% incidence of 
aneurysm rupture after EVAR. Risk factors for aneurysm rupture included type Ia 
and III endoleak, graft migration, and graft bending [84].
Intermittent claudication after EVAR is usually related to the coverage of the 
hypogastric arteries by the stent. The ACE study found a 14% incidence of claudica-
tion after EVARs. In most patients, it usually resolves over time; however, in about 
15% of patients, this complication persists [74, 85].
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